Logo

OpiCalc

FavoritesSpecialtiesDrugsGuidelinesMost Used

All Specialties

OpiCalc Logo
FavoritesSpecialtiesDrugsGuidelinesMost Used
FavesSpecsDrugsGuidesTop
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required
Ready for the Bedside

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2018-2026

•

All Rights Reserved

Registry Hub

Therapeutic Classification

vinca alkaloid Registry

Clinical reference for vinca alkaloid medications. Access safety monographs, dosing adjustments, and drug-drug interactions for all registered brand names and generics in this class.

Registered Medications (vinca alkaloid)

This therapeutic registry is dynamically synthesized from professional clinical sources. Listing of a medication does not imply equivalence; refer to individual monographs for head-to-head pharmacological data.

MedicationTherapeutic ClassMaternal Safety

NAVELBINE

Comprehensive clinical and safety monograph for NAVELBINE (NAVELBINE).

Vinca Alkaloid Antineoplastic

caution

NAVSTEL

Comprehensive clinical and safety monograph for NAVSTEL (NAVSTEL).

Vinca Alkaloid Antineoplastic

caution

ONCOVIN

Comprehensive clinical and safety monograph for ONCOVIN (ONCOVIN).

Vinca Alkaloid

caution

VELBAN

Comprehensive clinical and safety monograph for VELBAN (VELBAN).

Antineoplastic Vinca Alkaloid

caution

VINBLASTINE SULFATE

Strong CYP3A4 inhibitors may increase levels Can cause severe myelosuppression and extravasation injury.

Vinca Alkaloid

avoid

VINCASAR PFS

Comprehensive clinical and safety monograph for VINCASAR PFS (VINCASAR PFS).

Vinca Alkaloid Antineoplastic

caution

VINCREX

Comprehensive clinical and safety monograph for VINCREX (VINCREX).

Vinca Alkaloid Antineoplastic

caution

VINCRISTINE SULFATE

Strong CYP3A4 inhibitors may increase levels Can cause severe peripheral neuropathy and extravasation injury.

Vinca Alkaloid

avoid

VINCRISTINE SULFATE PFS

Strong CYP3A4 inhibitors may increase levels Can cause severe peripheral neuropathy and extravasation injury.

Vinca Alkaloid

avoid

VINORELBINE TARTRATE

Strong CYP3A4 inhibitors may increase levels Can cause severe myelosuppression and extravasation injury.

Vinca Alkaloid

avoid